Provided by Tiger Trade Technology Pte. Ltd.

Immuneering Corp

4.99
-0.2200-4.22%
Post-market: 5.100.1100+2.20%19:30 EDT
Volume:793.87K
Turnover:4.01M
Market Cap:322.20M
PE:-5.09
High:5.21
Open:5.21
Low:4.94
Close:5.21
52wk High:10.08
52wk Low:3.86
Shares:64.57M
Float Shares:49.21M
Volume Ratio:1.61
T/O Rate:1.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9796
EPS(LYR):-1.2729
ROE:-52.15%
ROA:-32.77%
PB:1.69
PE(LYR):-3.92

Loading ...

Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Immuneering (IMRX)

TIPRANKS
·
Aug 27

Immuneering Enrolls Phase 3 MAPKeeper 301 Trial of Atebimetinib Combo in First-Line Metastatic Pancreatic Cancer

Reuters
·
Aug 27

aTyr Pharma Q2 Net Loss Narrows

Reuters
·
Aug 08

Canada's Xenon Pharma Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 07

HC Wainwright Initiates Immuneering at Buy With $14 Price Target

MT Newswires Live
·
Aug 06

Immuneering Initiated at Buy by HC Wainwright & Co.

Dow Jones
·
Aug 06

Immuneering Corporation : H.c. Wainwright Initiates Coverage with Buy Rating

THOMSON REUTERS
·
Aug 06

Arcus Biosciences Q2 Revenue Falls Sharply on Lower License Income

Reuters
·
Aug 06

Tenaya Therapeutics Q2 Net Loss Widens on Impairment Charge

Reuters
·
Aug 06

Biopharma Firm Xencor's Q2 Revenue Beats on Royalty Revenue, Milestone Payments

Reuters
·
Aug 06

Black Diamond Therapeutics Q2 Net Loss Narrows Year over Year

Reuters
·
Aug 06

Immuneering Expects Cash Runway to Fund Operations into 2029

Reuters
·
Aug 05

Immuneering Q2 EPS $(0.27), Inline

Benzinga Earnings
·
Aug 05

Immuneering Reports Second Quarter 2026 Financial Results and Provides Business Updates

THOMSON REUTERS
·
Aug 05

Immuneering publishes preclinical data on atebimetinib in Cancer Research

TIPRANKS
·
Jul 22

Immuneering Flags New Press Release on Atebimetinib Preclinical Study Publication in Cancer Research

Reuters
·
Jul 22

Immuneering Corp : Needham Raises Target Price to $18 from $11

THOMSON REUTERS
·
Jul 20

Immuneering is Maintained at Buy by Needham

Dow Jones
·
Jul 20

Immuneering Corporation Announces Grants of Inducement Awards

GlobeNewswire
·
Jul 18

Immuneering CFO Andrew Gengos Files Initial Beneficial Ownership Statement

Reuters
·
Jul 17